CRP is one of the biomarkers associated with the severity of COVID-19 (although it is a nonspecific inflammation biomarker), and elevated levels are observed in hospitalized COVID-19 patients, especially those with severe disease (Guan et al., 2020), generating a systemic inflammatory response and increasing the release of pro-inflammatory cytokines. The gene discussed is CRP; the disease is COVID-19.